Holen Sie sich die Stockscreener-App
0.591
1.48%
-0.0089
Handel nachbörslich:
.58
-0.011
-1.86%
Barinthus Biotherapeutics Plc Adr Aktie (BRNS) Neueste Nachrichten
Barinthus Biotherapeutics (Nasdaq: BRNS) details Q2 loss, cash and Clywedog merger plan - Stock Titan
Barinthus Biotherapeutics plc Sponsored ADR Revenue Breakdown – GETTEX:2AB - TradingView
All You Need to Know About Bright Minds Biosciences Inc. (DRUG) Rating Upgrade to Strong Buy - Yahoo Finance
What Makes Protara Therapeutics (TARA) a New Buy Stock - Yahoo Finance
Price to sales forward of Barinthus Biotherapeutics plc Sponsored ADR – DUS:2AB - TradingView
Enterprise value to revenue forward of Barinthus Biotherapeutics plc Sponsored ADR – DUS:2AB - TradingView
Price to earnings forward of Barinthus Biotherapeutics plc Sponsored ADR – DUS:2AB - TradingView
2AB Forecast — Price Target — Prediction for 2027 - TradingView
Burke & Herbert (BHRB) Upgraded to Buy: Here's Why - Yahoo Finance
All You Need to Know About Sera Prognostics (SERA) Rating Upgrade to Buy - Yahoo Finance
Bayer (BAYRY) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
All You Need to Know About Promis Neurosciences (PMN) Rating Upgrade to Buy - Yahoo Finance
Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
BeOne Medicines Ltd.Sponsored ADR (ONC) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
Bain Capital Specialty (BCSF) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
BRNSBarinthus Biotherapeutics Plc ADR Stock Price and Quote - Finviz
Barinthus Biotherapeutics shareholders approve scheme of arrangement - Investing.com
MARKER THERAPEUTICS (MRKR) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
What Makes Biorestorative Therapies (BRTX) a New Buy Stock - Yahoo Finance
Are KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders? - Morningstar
USANA Health (USNA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Sahm
Barinthus Biotherapeutics (NASDAQ: BRNS) cuts Q1 loss while pursuing Clywedog merger - Stock Titan
What Makes Haleon PLC Sponsored ADR (HLN) a New Buy Stock - Yahoo Finance
Why Brainsway (BWAY) Might be Well Poised for a Surge - Yahoo Finance
ProShares Russell 2000 Dividend Growers ETF $SMDV Shares Sold by Capital Investment Advisors LLC - Defense World
All You Need to Know About Theravance Bio (TBPH) Rating Upgrade to Strong Buy - Yahoo Finance
Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's Why - Yahoo Finance
Are NSA, ULY, ESQ, BRNS Obtaining Fair Deals for their Shareholders? - Finviz
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
Biofrontera Inc. (BFRI) Upgraded to Buy: Here's Why - Yahoo Finance
Haleon PLC Sponsored ADR (HLN) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance
Banco Santander-Brazil (BSBR) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Sarepta Therapeutics (SRPT) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
BioHarvest Sciences Inc. (NASDAQ:BHST) Sees Large Increase in Short Interest - Defense World
Arbutus (ABUS) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Viatris (VTRS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Biohaven Ltd. (BHVN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Should I buy Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) - Zacks Investment Research
Barinthus Bio reports positive initial data from celiac therapy trial - Investing.com
Barinthus Bio joins forces with metabolic disease biotech in reverse merger - Fierce Biotech
Liminatus Pharma (LIMN) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Surging Earnings Estimates Signal Upside for Brainsway (BWAY) Stock - Yahoo Finance
Europe Shingles Vaccine Market Size & Outlook, 2025-2030 - Grand View Research
BioCryst (BCRX) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
Improved Revenues Required Before Barinthus Biotherapeutics plc (NASDAQ:BRNS) Stock's 29% Jump Looks Justified - Sahm
BRNS: Q1 2025 saw a $19.6M net loss and a strategic pivot to immunology, with cash runway into 2027 - TradingView
BRNS: Antigen-specific immunotherapies advance with strong clinical progress and robust financials - TradingView
Barinthus Biotherapeutics plc (ADR) (BRNS) Live Share Price, Invest From India - INDmoney
BRNS: 2024 net loss narrowed to $61.2M; major restructuring extends cash runway into 2027 - TradingView
BRNS: Promising HBV and celiac programs advance, with key data and strong financials supporting growth - TradingView
BRNS: Q3 saw $15M royalty revenue, reduced net loss, and key clinical trial milestones achieved - TradingView
Mexico Shingles Vaccine Market Size & Outlook, 2025-2030 - Grand View Research
Asia Pacific Shingles Vaccine Market Size & Outlook, 2030 - Grand View Research
North America Shingles Vaccine Market Size & Outlook, 2030 - Grand View Research
BRNS: HBV and celiac programs prioritized as cash runway extends into Q2 2026 - TradingView
What is the current Price Target and Forecast for Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) - Zacks Investment Research
Middle East & Africa Shingles Vaccine Market Size & Outlook, 2030 - Grand View Research
Barinthus Biotherapeutics (BRNS) Stock Forecast and Price Target 2026 - MarketBeat
Barinthus Biotherapeutics plc (BRNS) stock price, news, quote and history - Yahoo Finance UK
Barinthus Bio reports mixed results in APOLLO trial - Investing.com
Barinthus Biotherapeutics plc ADR Each Rep 1 Ord Share Spon share price - Hargreaves Lansdown
Barinthus Biotherapeutics plc (BRNS) Stock Price, News, Quote & History - Yahoo! Finance Canada
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):